Citations (47)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Shaoming Song, Mingzhen Bai, Xiaofei Li, Shiyi Gong, Wenwen Yang, Caining Lei, Hongwei Tian, Moubo Si, Xiangyong Hao & Tiankang Guo. (2022) Early predictive value of circulating biomarkers for sorafenib in advanced hepatocellular carcinoma. Expert Review of Molecular Diagnostics 22:3, pages 361-378.
Read now
Read now
Xihai Wang, Hongyuan Liang & Zaiming Lu. (2020) Efficacy of transarterial chemoembolization compared with radiofrequency ablation for the treatment of recurrent hepatocellular carcinoma after radiofrequency ablation . Minimally Invasive Therapy & Allied Technologies 29:6, pages 344-352.
Read now
Read now
William H. Smith, Amy S. Law, Miriam Hulkower, Heather M. McGee, Eric J. Lehrer, Myron Schwartz, Bachir Taouli, Max Sung & Michael Buckstein. (2020) The effect of radiation therapy on the objective response and outcomes with nivolumab for hepatocellular carcinoma. Acta Oncologica 59:8, pages 940-943.
Read now
Read now
Ying Wang, Xin-Hong He, Li-Chao Xu, Hao-Zhe Huang, Guo-Dong Li, Yao-Hui Wang, Wen-Tao Li & Guang-Zhi Wang. (2019) CT-guided cryoablation for unresectable pelvic recurrent colorectal cancer: a retrospective study. OncoTargets and Therapy 12, pages 1379-1387.
Read now
Read now
Mi Na Kim, Beom Kyung Kim, Kwang-Hyub Han & Seung Up Kim. (2015) Evolution from WHO to EASL and mRECIST for hepatocellular carcinoma: considerations for tumor response assessment. Expert Review of Gastroenterology & Hepatology 9:3, pages 335-348.
Read now
Read now
Tushar Patel & Denise Harnois. (2014) Assessment of response to therapy in hepatocellular carcinoma. Annals of Medicine 46:3, pages 130-137.
Read now
Read now
Articles from other publishers (41)
Chong-Ke Zhao, Xin Guan, Yin-Ying Pu, Bo-Yang Zhou, Li-Fan Wang, Yi-Kang Sun, Hao-Hao Yin, Han-Sheng Xia, Xi Wang, Hong Han & Hui-Xiong Xu. (2024) Response Evaluation Using Contrast-Enhanced Ultrasound for Unresectable Advanced Hepatocellular Carcinoma Treated With Tyrosine Kinase Inhibitors Plus Anti-PD-1 Antibody Therapy. Ultrasound in Medicine & Biology 50:1, pages 142-149.
Crossref
Crossref
Andres F. Espinoza, Kalyani R. Patel, Priya B. Shetty, Richard S. Whitlock, Pavel Sumazin, Xinjian Yu, Stephen F. Sarabia, Martin Urbicain, Andras Heczey, Prakash Masand, Sarah E. Woodfield, Dolores H. López‐Terrada & Sanjeev A. Vasudevan. (2023) Navigating relapsed hepatoblastoma: Predictive factors and surgical treatment strategy. Cancer Medicine.
Crossref
Crossref
Haohao Lu, Bin Liang, Xiangwen Xia & Chuansheng Zheng. (2023) Efficacy and safety analysis of TACE + Donafenib + Toripalimab versus TACE + Sorafenib in the treatment of unresectable hepatocellular carcinoma: a retrospective study. BMC Cancer 23:1.
Crossref
Crossref
Daniel Stocker, Michael J. King, Maria El Homsi, Jeffrey Gnerre, Brett Marinelli, Moritz Wurnig, Myron Schwartz, Edward Kim & Bachir Taouli. (2023) Early post-treatment MRI predicts long-term hepatocellular carcinoma response to radiation segmentectomy. European Radiology.
Crossref
Crossref
Xinhua Zou, Qingyu Xu, Ran You & Guowen Yin. (2023) Evaluating the Benefits of TACE Combined with Lenvatinib Plus PD-1 Inhibitor for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus. Advances in Therapy 40:4, pages 1686-1704.
Crossref
Crossref
Aleksandar Filipović, Dragan Mašulović, Marko Živanović, Tamara Filipović, Dušan Bulatović, Miloš Zakošek, Dejan Nikolić & Danijel Galun. (2022) Impact of the COVID-19 Pandemic on the Outcomes of Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma: A Single Center Experience from a Developing Country. Medicina 58:12, pages 1701.
Crossref
Crossref
Tanaporn Prateepchaiboon, Arunchai Chang, Nuttanit Pungpipattrakul, Keerati Akarapatima, Attapon Rattanasupar, Apiradee Songjamrat, Songklod Pakdeejit & Teerha Piratvisuth. (2022) Factors affecting prognosis in hepatocellular carcinoma patients post-transarterial chemoembolization. Indian Journal of Gastroenterology 41:4, pages 352-361.
Crossref
Crossref
Attapon Rattanasupar, Arunchai Chang, Tanaporn Prateepchaiboon, Nuttanit Pungpipattrakul, Keerati Akarapatima, Apiradee Songjamrat, Songklod Pakdeejit, Varayu Prachayakul & Teerha Piratvisuth. (2022) Impact of alcohol consumption on treatment outcome of hepatocellular carcinoma patients with viral hepatitis who underwent transarterial chemoembolization. World Journal of Hepatology 14:6, pages 1162-1172.
Crossref
Crossref
Xiao Wu, Julius Chapiro & Ajay Malhotra. (2021) Cost-Effectiveness of Imaging Tumor Response Criteria in Hepatocellular Cancer After Transarterial Chemoembolization. Journal of the American College of Radiology 18:7, pages 927-934.
Crossref
Crossref
Víctor Lopez-Lopez, Roberto Brusadin, Asunción López-Conesa, Antonio Capel, Álvaro Navarro-Barrios, Valentín Cayuela, Elena Lopez-Banet, Alejandro Garzón-Arana, Pascual Parrilla-Paricio & Ricardo Robles-Campos. (2021) Preoperative transarterial chemoembolization for laparoscopic liver resection in Child A cirrhotic patients with hepatocellular carcinoma. Langenbeck's Archives of Surgery 406:3, pages 763-771.
Crossref
Crossref
Youngjong Cho, Sangjoon Lee & Sung-Joon Park. (2021) Effectiveness of intraprocedural dual-phase cone-beam computed tomography in detecting hepatocellular carcinoma and improving treatment outcomes following conventional transarterial chemoembolization. PLOS ONE 16:1, pages e0245911.
Crossref
Crossref
Marcel C. LangenbachThomas J. VoglGulia SaidJan-Erik ScholtzRenate HammerstinglTatjana Gruber-Rouh. (2021) Lipiodol as a Predictive Indicator for Therapy Response to Transarterial Chemoembolization of Hepatocellular Carcinoma. Cancer Biotherapy and Radiopharmaceuticals.
Crossref
Crossref
Jae Seung Lee, Hong Jun Choi, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Song-Ee Baek, Yong Eun Chung, Mi-Suk Park, Myeong-Jin Kim, Hyungjin Rhee & Seung Up Kim. (2020) The Modified Response Evaluation Criteria in Solid Tumors (RECIST) Yield a More Accurate Prognoses Than the RECIST 1.1 in Hepatocellular Carcinoma Treated with Transarterial Radioembolization. Gut and Liver 14:6, pages 765-774.
Crossref
Crossref
Chan Park, Dong Il Gwon, Hee Ho Chu, Jong Woo Kim, Jin Hyoung Kim & Gi-Young Ko. (2020) Correlation of tumor response on CT with pathologically proven necrosis in hepatocellular carcinoma treated by conventional transcatheter arterial chemoembolization: threshold value of intratumoral Lipiodol accumulation predicting tumor necrosis. Abdominal Radiology.
Crossref
Crossref
Jules Gregory, Marco Dioguardi Burgio, Giuseppe Corrias, Valérie Vilgrain & Maxime Ronot. (2020) Evaluation of liver tumour response by imaging. JHEP Reports 2:3, pages 100100.
Crossref
Crossref
Yufu Peng, Fei Liu, Hongwei Xu, Yonggang Wei & Bo Li. (2020) Is laparoscopic liver resection suitable for selected patients with BCLC stage B HCC? A propensity score-matched analysis. HPB 22:4, pages 595-602.
Crossref
Crossref
Feng Qi, Lingxiao Wang, Peixin Huang, Zhiying Zhao, Biwei Yang & Jinglin Xia. (2019) Time‑series clustering of cytokine expression after transarterial chemoembolization in patients with hepatocellular carcinoma. Oncology Letters.
Crossref
Crossref
Lauranne Piron, Julien Le Roy, Christophe Cassinotto, Julien Delicque, Ali Belgour, Carole Allimant, Jean-Paul Beregi, Joel Greffier, Nicolas Molinari & Boris Guiu. (2019) Radiation Exposure During Transarterial Chemoembolization: Angio-CT Versus Cone-Beam CT. CardioVascular and Interventional Radiology 42:11, pages 1609-1618.
Crossref
Crossref
Lale Kostakoglu & Grzegorz S. Nowakowski. (2019) End-of-Treatment PET/Computed Tomography Response in Diffuse Large B-Cell Lymphoma. PET Clinics 14:3, pages 307-315.
Crossref
Crossref
Xin-Rong Zhang, Jun Ouyang & Jing-Yuan Huang. (2019) Quantitative evaluation of blood perfusion in hepatocellular carcinoma after transcatheter arterial chemoembolization by contrast-enhanced ultrasound. World Chinese Journal of Digestology 27:4, pages 276-281.
Crossref
Crossref
Moon Hyung Choi, Ga Eun Park, Soon Nam Oh, Michael Yong Park, Sung Eun Rha, Young Joon Lee, Seung Eun Jung & Joon-Il Choi. (2018) Reproducibility of mRECIST in Measurement and Response Assessment for Hepatocellular Carcinoma Treated by Transarterial Chemoembolization. Academic Radiology 25:11, pages 1363-1373.
Crossref
Crossref
Yu-Chun Yen, Han-Lin Hsu, Jer-Hwa Chang, Wei-Cheng Lin, Yin-Chun Chang, Chia-Lun Chang, Jyh-Ming Chow, Kevin Sheng-Po Yuan, Alexander T.H. Wu & Szu-Yuan Wu. (2018) Efficacy of thoracic radiotherapy in patients with stage IIIB–IV epidermal growth factor receptor-mutant lung adenocarcinomas who received and responded to tyrosine kinase inhibitor treatment. Radiotherapy and Oncology 129:1, pages 52-60.
Crossref
Crossref
Mi Young Jeon, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang‐Hyub Han, Song‐Ee Baek, Hye Soo Kim, Seung Up Kim & Mi Suk Park. (2018) Reproducibility of European Association for the Study of the Liver criteria and modified Response Evaluation Criteria in Solid Tumors in patients treated with sorafenib. Liver International 38:9, pages 1655-1663.
Crossref
Crossref
Francesco Tovoli, Matteo Renzulli, Giulia Negrini, Stefano Brocchi, Alessia Ferrarini, Andrea Andreone, Francesca Benevento, Rita Golfieri, Antonio Maria Morselli-Labate, Marianna Mastroroberto, Radu Ion Badea & Fabio Piscaglia. (2018) Inter-operator variability and source of errors in tumour response assessment for hepatocellular carcinoma treated with sorafenib. European Radiology 28:9, pages 3611-3620.
Crossref
Crossref
Farnaz Najmi Varzaneh, Ankur Pandey, Mounes Aliyari Ghasabeh, Nannan Shao, Pegah Khoshpouri, Pallavi Pandey, Manijeh Zarghampour, Daniel Fouladi, Robert Liddell, Robert Albert Anders & Ihab R. Kamel. (2018) Prediction of post-TACE necrosis of hepatocellular carcinoma usingvolumetric enhancement on MRI and volumetric oil deposition on CT, with pathological correlation. European Radiology 28:7, pages 3032-3040.
Crossref
Crossref
Wei Zhang, Chang Liu, Yifei Tan, Li Jiang, Lunan Yan, Jiayin Yang & Tianfu Wen. (2018) Role of liver resection in treating intermediate and advanced stage adolescent and young adult hepatocellular carcinoma patients: A propensity-matching cohort study. International Journal of Surgery 54, pages 259-264.
Crossref
Crossref
Jian Zhou, Hui-Chuan Sun, Zheng Wang, Wen-Ming Cong, Jian-Hua Wang, Meng-Su Zeng, Jia-Mei Yang, Ping Bie, Lian-Xin Liu, Tian-Fu Wen, Guo-Hong Han, Mao-Qiang Wang, Rui-Bao Liu, Li-Gong Lu, Zheng-Gang Ren, Min-Shan Chen, Zhao-Chong Zeng, Ping Liang, Chang-Hong Liang, Min Chen, Fu-Hua Yan, Wen-Ping Wang, Yuan Ji, Wen-Wu Cheng, Chao-Liu Dai, Wei-Dong Jia, Ya-Ming Li, Ye-Xiong Li, Jun Liang, Tian-Shu Liu, Guo-Yue Lv, Yi-Lei Mao, Wei-Xin Ren, Hong-Cheng Shi, Wen-Tao Wang, Xiao-Ying Wang, Bao-Cai Xing, Jian-Ming Xu, Jian-Yong Yang, Ye-Fa Yang, Sheng-Long Ye, Zheng-Yu Yin, Bo-Heng Zhang, Shui-Jun Zhang, Wei-Ping Zhou, Ji-Ye Zhu, Rong Liu, Ying-Hong Shi, Yong-Sheng Xiao, Zhi Dai, Gao-Jun Teng, Jian-Qiang Cai, Wei-Lin Wang, Jia-Hong Dong, Qiang Li, Feng Shen, Shu-Kui Qin & Jia Fan. (2018) Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition). Liver Cancer 7:3, pages 235-260.
Crossref
Crossref
Ania Kielar, Kathryn J. Fowler, Sara Lewis, Vahid Yaghmai, Frank H. Miller, Hooman Yarmohammadi, Charles Kim, Victoria Chernyak, Takeshi Yokoo, Jeffrey Meyer, Isabel Newton & Richard K. Do. (2017) Locoregional therapies for hepatocellular carcinoma and the new LI-RADS treatment response algorithm. Abdominal Radiology 43:1, pages 218-230.
Crossref
Crossref
Stephen P. Reis, Patrick D. Sutphin, Amit G. Singal, Richard Grzybowski, Stephen Fisher, Christopher Ball, Yin Xi, Simer Grewal & Sanjeeva P. Kalva. (2017) Tumor Enhancement and Heterogeneity Are Associated With Treatment Response to Drug-Eluting Bead Chemoembolization for Hepatocellular Carcinoma. Journal of Computer Assisted Tomography 41:2, pages 289-293.
Crossref
Crossref
Joern Henze, David Maintz & Thorsten Persigehl. (2016) RECIST 1.1, irRECIST 1.1, and mRECIST: How to Do. Current Radiology Reports 4:9.
Crossref
Crossref
Young-Hsiang Lin, Shih-Kai Hung, Wen-Yen Chiou, Moon-Sing Lee, Bing-Jie Shen, Liang-Cheng Chen, Dai-Wei Liu, Wei-Ta Tsai, Po-Hao Lin, Yi-Ting Shih, Feng-Chun Hsu, Shiang-Jiun Tsai, Michael W.Y. Chan & Hon-Yi Lin. (2016) Significant symptoms alleviation and tumor volume reduction after combined simultaneously integrated inner-escalated boost and volumetric-modulated arc radiotherapy in a patient with unresectable bulky hepatocellular carcinoma. Medicine 95:34, pages e4717.
Crossref
Crossref
Adeel R. Seyal, Fernanda D. Gonzalez‐Guindalini, Atilla Arslanoglu, Carla B. Harmath, Robert J. Lewandowski, Riad Salem & Vahid Yaghmai. (2015) Reproducibility of mRECIST in assessing response to transarterial radioembolization therapy in hepatocellular carcinoma. Hepatology 62:4, pages 1111-1121.
Crossref
Crossref
Kazuko Sakai, Haruhiko Takeda, Norihiro Nishijima, Etsuro Orito, Kouji Joko, Yasushi Uchida, Namiki Izumi, Kazuto Nishio & Yukio Osaki. (2015) Targeted DNA and RNA sequencing of fine-needle biopsy FFPE specimens in patients with unresectable hepatocellular carcinoma treated with sorafenib. Oncotarget 6:25, pages 21636-21644.
Crossref
Crossref
Bruno Vincenzi, Massimo Di Maio, Marianna Silletta, Loretta D?Onofrio, Chiara Spoto, Maria Carmela Piccirillo, Gennaro Daniele, Francesca Comito, Eliana Maci, Giuseppe Bronte, Antonio Russo, Daniele Santini, Francesco Perrone & Giuseppe Tonini. (2015) Prognostic Relevance of Objective Response According to EASL Criteria and mRECIST Criteria in Hepatocellular Carcinoma Patients Treated with Loco-Regional Therapies: A Literature-Based Meta-Analysis. PLOS ONE 10:7, pages e0133488.
Crossref
Crossref
Bin Qiu. (2015) Combined transjugular intrahepatic portosystemic shunt and other interventions for hepatocellular carcinoma with portal hypertension. World Journal of Gastroenterology 21:43, pages 12439.
Crossref
Crossref
Matheus Alvarez, Diana Rodrigues de Pina, Fernando Gomes Romeiro, Sérgio Barbosa Duarte & José Arruda Ricardo de Miranda. (2014) Wavelet-based algorithm to the evaluation of contrasted hepatocellular carcinoma in CT-images after transarterial chemoembolization. Radiation Oncology 9:1.
Crossref
Crossref
WENJUN MOU, HUI XUE, HONGLI TONG, SHENGJIE SUN, ZHUHONG ZHANG, CHUNYAN ZHANG, QIYU SUN, JING DONG, XINYU WEN, GUANGTAO YAN & YAPING TIAN. (2014) Prognostic value of serum leptin in advanced lung adenocarcinoma patients with cisplatin/pemetrexed chemotherapy. Oncology Letters 7:6, pages 2073-2078.
Crossref
Crossref
Matheus Alvarez, Diana Rodrigues de Pina, Guilherme Giacomini, Fernando Gomes Romeiro, Sérgio Barbosa Duarte, Seizo Yamashita & José Ricardo de Arruda Miranda. Wavelets based algorithm for the evaluation of enhanced liver areas. Wavelets based algorithm for the evaluation of enhanced liver areas.
Ann Lii Cheng, Deepak Amarapurkar, Yee Chao, Pei-Jer Chen, Jean-François Geschwind, Khean L. Goh, Kwang-Hyub Han, Masatoshi Kudo, Han Chu Lee, Rheun-Chuan Lee, Laurentius A. Lesmana, Ho Yeong Lim, Seung Woon Paik, Ronnie T. Poon, Chee-Kiat Tan, Tawesak Tanwandee, Gaojun Teng & Joong-Won Park. (2014) Re-evaluating transarterial chemoembolization for the treatment of Hepatocellular Carcinoma: Consensus recommendations and review by an International Expert Panel. Liver International 34:2, pages 174-183.
Crossref
Crossref
Yuo-Chen Kuo, Maureen P. Kohi, David M. Naeger, Ricky T. Tong, K. Pallav Kolli, Andrew G. Taylor, Jeanne M. Laberge, Robert K. KerlanJr.Jr. & Nicholas Fidelman. (2013) Efficacy of TACE in TIPS Patients: Comparison of Treatment Response to Chemoembolization for Hepatocellular Carcinoma in Patients With and Without a Transjugular Intrahepatic Portosystemic Shunt. CardioVascular and Interventional Radiology 36:5, pages 1336-1343.
Crossref
Crossref
V. Patil, V. Noronha, A. Joshi, Vamshi Muddu Krishna, S. Juvekar, Gauri Pantvaidya, Pankaj Chaturvedi, D. Chaukar, Supreeta Arya, Aswari Patil, B. Bhosale, A. Dongre, A. K. Dcruz & K. Prabhash. (2013) Is There a Limitation of RECIST Criteria in Prediction of Pathological Response, in Head and Neck Cancers, to Postinduction Chemotherapy?. ISRN Oncology 2013, pages 1-6.
Crossref
Crossref